SuperworthPalisade Bio shares outstanding PALI
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 211.4M
- On a year earlier
- +4306.4%
- more shares
Palisade Bio had 211.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 4306.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 2.2M | +250% |
| FY2023 | 616.1K | +415% |
| FY2022 | 119.5K | +3007% |
| FY2020 | 3.8K | +260% |
| FY2019 | 1.1K | +533% |
| FY2018 | 169 | +1% |
| FY2017 | 168 | +62% |
| FY2016 | 104 | +32% |
| FY2015 | 79 | +4% |
| FY2014 | 75 | +14% |
| FY2013 | 66 | +13% |
| FY2012 | 58 | +40% |
| FY2011 | 42 | +4% |
| FY2010 | 40 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 211.4M | +4306% | |
| Q1 FY26 | 209.7M | +4272% | |
| Q3 FY25 | 7.5M | +398% | |
| Q2 FY25 | 4.8M | +291% | |
| Q1 FY25 | 4.8M | +524% | |
| Q4 FY24 | 2.2M | +250% | |
| Q3 FY24 | 1.5M | +206% | |
| Q2 FY24 | 1.2M | +187% | |
| Q1 FY24 | 768.1K | +167% | |
| Q4 FY23 | 616.1K | +415% | |
| Q3 FY23 | 489.6K | +654% | |
| Q2 FY23 | 427.9K | +1481% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Palisade Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.